Autotelic Bio sell "ATB-301"
Basic Information
1.5K
86
36
4.8(26)
Category
Subcategory & Sub-subcategory
/
Trade Type
Sell
Product Name
ATB-301
Manufacturer(s)
- -
Specifications
- Formulation Type: TGF-β2-targeting antisense oligonucleotide (ASO) combined with IL-2 biologic therapy
- Regulatory Status: Phase Ib clinical trial (investigational, not yet approved)
- Application: Combination cancer immunotherapy targeting the TGF-β2 and IL-2 signalling pathway
Documents
No documents
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Matched Products & Services
B2B matches based on trade type, category, specifications & price range
Similar Products & Services
Products & Services related to what you're viewing
People Also Viewed
Other products & services viewed by people who looked at this product
Leave your rating & comment